Amendment of the low-density lipoprotein cholesterol target in the 'Chinese Guidelines for the Prevention and Treatment of Adult Dyslipidemia': Opinion
- PMID: 29063018
- PMCID: PMC5643599
- DOI: 10.1016/j.cdtm.2016.04.001
Amendment of the low-density lipoprotein cholesterol target in the 'Chinese Guidelines for the Prevention and Treatment of Adult Dyslipidemia': Opinion
References
-
- Stone N.J., Robinson J., Lichtenstein A.H. 2013ACC/AHAGuideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JACC. 2014;63:2889–2934. - PubMed
-
- Rabar S., Harker M., Flynn N., Wierzbicki A.S., On behalf of the Guideline Development Group Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ. 2014;349:1–6. - PubMed
-
- Expert Panel of Chinese Guidelines for the Treatment and Prevention of Dyslipidemia Chinese guidelines for the treatment and prevention of dyslipidemia. Chin J Cardiol. 2007;35:390–410.
-
- Cannon C.P., Blazing M.A., Giugliano R.P., IMPROVE-IT Investigators Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015 18;372:2387–2397. - PubMed
-
- Williams K.J., Feig J.E., Fisher E.A. Rapid regression of atherosclerosis: insights from the clinical and experimental literature. Nat Clin Pract Cardiovasc Med. 2008;5:91–102. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
